Published in Brain Res Bull on May 27, 2009
Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth. Proc Natl Acad Sci U S A (2011) 1.20
Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Prog Retin Eye Res (2012) 1.05
Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy. Invest Ophthalmol Vis Sci (2011) 0.93
Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea. Nanomedicine (2011) 0.91
Impaired autophagy and delayed autophagic clearance of transforming growth factor β-induced protein (TGFBI) in granular corneal dystrophy type 2. Autophagy (2012) 0.90
Gamma-irradiation reduces the allogenicity of donor corneas. Invest Ophthalmol Vis Sci (2012) 0.90
Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization. Mol Vis (2009) 0.90
Comparison of genome-wide gene expression in suture- and alkali burn-induced murine corneal neovascularization. Mol Vis (2011) 0.87
Cellular and extracellular matrix modulation of corneal stromal opacity. Exp Eye Res (2014) 0.87
Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin. J Biol Chem (2011) 0.86
Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures. Mol Pharm (2013) 0.80
Vimentin knockdown decreases corneal opacity. Invest Ophthalmol Vis Sci (2014) 0.78
Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model. Graefes Arch Clin Exp Ophthalmol (2015) 0.77
CXCL12/CXCR4 axis regulates neovascularization and lymphangiogenesis in sutured corneas in mice. Mol Med Rep (2016) 0.77
Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. Surv Ophthalmol (2015) 0.77
Gelatin-Based Materials in Ocular Tissue Engineering. Materials (Basel) (2014) 0.76
Peptide Amphiphiles in Corneal Tissue Engineering. J Funct Biomater (2015) 0.76
Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization. Int J Ophthalmol (2014) 0.76
Corneal endothelial cell density in healthy Caucasian population. Saudi J Ophthalmol (2016) 0.75
Effect of corneal light scatter on vision: a review of the literature. Int J Ophthalmol (2016) 0.75
Acacia honey accelerates in vitro corneal ulcer wound healing model. BMC Complement Altern Med (2016) 0.75
Single-cell analysis reveals IGF-1 potentiation of inhibition of the TGF-β/Smad pathway of fibrosis in human keratocytes in vitro. Sci Rep (2016) 0.75
Identification of functional pathways associated with the conditional ablation of serum response factor in Dstncorn1 mice. Mol Med Rep (2016) 0.75
Acellular ostrich corneal stroma used as scaffold for construction of tissue-engineered cornea. Int J Ophthalmol (2016) 0.75
Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis. Medicine (Baltimore) (2014) 0.75
Genetic modification of corneal neovascularization in Dstn (corn1) mice. Mamm Genome (2013) 0.75
Lack of association between VAP-1/SSAO activity and corneal neovascularization in a rabbit model. J Neural Transm (Vienna) (2013) 0.75
Tissue and cellular characterisation of nucleolin in a murine model of corneal angiogenesis. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
[New possibilities for ocular surface reconstruction: collagen membranes and biocompatible elastomer nanofibers]. Ophthalmologe (2014) 0.75
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell (1996) 13.95
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology (2006) 9.01
Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (1995) 8.23
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol (2003) 7.42
Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell (2002) 6.41
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest (2004) 5.59
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (1999) 5.53
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J (2002) 5.07
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem (1992) 4.92
Corneal avascularity is due to soluble VEGF receptor-1. Nature (2006) 4.77
The structure and transparency of the cornea. J Physiol (1957) 4.58
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J (2001) 3.88
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest (2005) 3.77
CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol (1997) 3.52
Corneal neovascularization. Curr Opin Ophthalmol (2001) 3.22
The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol (1992) 3.18
Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.17
Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med (2002) 3.16
The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem (1999) 3.08
Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res (1999) 3.03
The codependence of angiogenesis and chronic inflammation. FASEB J (1997) 3.02
Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell (1996) 3.01
Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development (2002) 2.68
Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res (2000) 2.63
The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J Cell Sci (1999) 2.55
Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A (2002) 2.30
Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem (1998) 2.28
Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci (2004) 2.27
Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol (2000) 2.24
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med (Berl) (1995) 2.12
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.12
Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. Invest Ophthalmol Vis Sci (2000) 2.10
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci (2007) 2.05
The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci (2003) 2.05
Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res (2005) 2.04
Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci (1996) 2.01
Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea (2003) 2.00
Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A (2004) 1.98
The crucial role of macrophages in lymphangiogenesis. J Clin Invest (2005) 1.97
Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci (2002) 1.82
Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res (2000) 1.81
Ocular neovascularization: an epidemiologic review. Surv Ophthalmol (1999) 1.79
Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med (2002) 1.79
Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci (1998) 1.77
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res (1997) 1.72
Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci (2000) 1.71
Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching. Eye (Lond) (2004) 1.70
The evolution of eyes. Annu Rev Neurosci (1992) 1.66
Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea (2006) 1.66
Confocal microscopic characterization of wound repair after photorefractive keratectomy. Invest Ophthalmol Vis Sci (1998) 1.63
Conditional deletion of the mouse Klf4 gene results in corneal epithelial fragility, stromal edema, and loss of conjunctival goblet cells. Mol Cell Biol (2006) 1.63
Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell (2005) 1.62
Proteoglycan expression during transforming growth factor beta -induced keratocyte-myofibroblast transdifferentiation. J Biol Chem (2001) 1.60
Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor). Hum Mol Genet (2003) 1.58
Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci (2000) 1.58
Inhibitory effect of triamcinolone acetonide on corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2005) 1.54
Kinetics of keratocyte proliferation in response to epithelial debridement. Exp Eye Res (2001) 1.51
Corneal abnormalities in Pax6+/- small eye mice mimic human aniridia-related keratopathy. Invest Ophthalmol Vis Sci (2003) 1.48
Proteoglycans and collagen fibre organization in human corneoscleral tissue. Exp Eye Res (1975) 1.48
Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res (2007) 1.48
Role of the neural crest in anterior segment development and disease. J Pediatr Ophthalmol Strabismus (1985) 1.47
The balance between corneal transparency and edema: the Proctor Lecture. Invest Ophthalmol Vis Sci (2006) 1.45
The relationship between morphology and transparency in the nonswelling corneal stroma of the shark. Invest Ophthalmol (1967) 1.44
Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett (2001) 1.44
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Acta Ophthalmol (2007) 1.41
Spontaneous corneal neovascularization in nude mice. Local imbalance between angiogenic and anti-angiogenic factors. Invest Ophthalmol Vis Sci (1993) 1.41
Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Invest Ophthalmol Vis Sci (2006) 1.39
Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun (2008) 1.39
Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr Eye Res (1998) 1.37
Pax6: more than meets the eye. Trends Genet (1995) 1.36
Keratocyte reflectivity and corneal haze. Exp Eye Res (2004) 1.36
Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol (2002) 1.33
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A (2003) 1.32
Corneal keratocytes: phenotypic and species differences in abundant protein expression and in vitro light-scattering. Invest Ophthalmol Vis Sci (2005) 1.32
Corneal crystallins and the development of cellular transparency. Semin Cell Dev Biol (2007) 1.31
Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol (2007) 1.28
Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol (2008) 1.27
A radioautographic study of the migration and fate of cranial neural crest cells in the chick embryo. Anat Rec (1966) 1.26
Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization. Lab Invest (2005) 1.26
Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci (2004) 1.26
Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes. Exp Eye Res (2006) 1.25
Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci (2007) 1.25
TNF-alpha regulates corneal Langerhans cell migration. J Immunol (1999) 1.24
Corn1: a mouse model for corneal surface disease and neovascularization. Invest Ophthalmol Vis Sci (1996) 1.24
Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea (2002) 1.23
Prenatal and postnatal growth of the human Descemet's membrane. Invest Ophthalmol Vis Sci (1984) 1.23
Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol Vis Sci (2003) 1.22
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier. Br J Ophthalmol (2006) 1.22
Vascular effects of photodynamic therapy. Anticancer Res (2002) 1.21
Collagens and collagen-related matrix components in the human and mouse eye. Prog Retin Eye Res (2004) 1.20
Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol (2007) 1.20
Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model. Am J Ophthalmol (2008) 1.19
A new three-dimensional model of the organization of proteoglycans and collagen fibrils in the human corneal stroma. Exp Eye Res (2004) 1.18
Very late antigen 1 blockade markedly promotes survival of corneal allografts. Arch Ophthalmol (2007) 1.17
Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand (2007) 1.17
Subconjunctival bevacizumab injection for corneal neovascularization. Cornea (2008) 1.16
Evolution of eyes. Curr Opin Neurobiol (2000) 1.15
Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 1.15
Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp Eye Res (2000) 1.15
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature (2008) 7.10
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med (2003) 6.61
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol (2003) 5.22
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90
Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A (2006) 3.25
Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.17
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell (2012) 2.81
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med (2009) 2.39
CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature (2009) 2.39
High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol (2007) 2.09
Late in-the-bag spontaneous intraocular lens dislocation: evaluation of 86 consecutive cases. Ophthalmology (2009) 1.68
Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity. Blood (2013) 1.56
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest (2006) 1.36
Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci U S A (2009) 1.36
Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 1.34
Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis. Invest Ophthalmol Vis Sci (2007) 1.25
Mediators of ocular angiogenesis. J Genet (2009) 1.17
Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci (2005) 1.13
Calcification of different designs of silicone intraocular lenses in eyes with asteroid hyalosis. Ophthalmology (2010) 1.10
Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol Ther (2011) 1.09
Corneal stroma PDGF blockade and myofibroblast development. Exp Eye Res (2008) 1.08
Anterior chamber intraocular lens, sutured posterior chamber intraocular lens, or glued intraocular lens: where do we stand? Curr Opin Ophthalmol (2012) 1.07
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife (2013) 1.06
Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization. PLoS One (2012) 1.00
ERK1/2 activation is a therapeutic target in age-related macular degeneration. Proc Natl Acad Sci U S A (2012) 0.99
Whirlin replacement restores the formation of the USH2 protein complex in whirlin knockout photoreceptors. Invest Ophthalmol Vis Sci (2011) 0.97
Objective comparison of 4 nonlongitudinal ultrasound modalities regarding efficiency and chatter. J Cataract Refract Surg (2012) 0.94
Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization. Cornea (2007) 0.93
Flt-1 intraceptor induces the unfolded protein response, apoptotic factors, and regression of murine injury-induced corneal neovascularization. Invest Ophthalmol Vis Sci (2006) 0.93
The capsule drug device: novel approach for drug delivery to the eye. Vision Res (2009) 0.93
Targeted drug and gene delivery systems for lung cancer therapy. Clin Cancer Res (2009) 0.92
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest (2014) 0.92
Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. ACS Nano (2013) 0.91
Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein. J Mol Graph Model (2007) 0.90
Horizons in therapy for corneal angiogenesis. Ophthalmology (2011) 0.90
Quality of vision and patient satisfaction after LASIK. Curr Opin Ophthalmol (2004) 0.90
Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). FASEB J (2012) 0.89
Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium. FASEB J (2009) 0.88
Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization. Invest Ophthalmol Vis Sci (2012) 0.88
Cataract surgery following phakic intraocular lens implantation. Curr Opin Ophthalmol (2010) 0.86
Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone. Invest Ophthalmol Vis Sci (2012) 0.85
Aquaporin-1 expression is decreased in human and mouse corneal endothelial dysfunction. Mol Vis (2004) 0.85
Pathology of 219 human cadaver eyes with 1-piece or 3-piece hydrophobic acrylic intraocular lenses: capsular bag opacification and sites of square-edged barrier breach. J Cataract Refract Surg (2011) 0.84
Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model. Cornea (2012) 0.83
Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization. Biochem Biophys Res Commun (2005) 0.83
Anti-SPARC oligopeptide inhibits laser-induced CNV in mice. Vision Res (2009) 0.83
Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation. J Control Release (2013) 0.82
Does expansion thoracoplasty improve the volume of the convex lung in a windswept thorax? J Pediatr Orthop (2009) 0.80
Pathology of 157 human cadaver eyes with round-edged or modern square-edged silicone intraocular lenses: analyses of capsule bag opacification. J Cataract Refract Surg (2011) 0.79
Gene delivery nanoparticles fabricated by supercritical fluid extraction of emulsions. Int J Pharm (2009) 0.79
Dry eye predisposes to corneal neovascularization and lymphangiogenesis after corneal injury in a murine model. Cornea (2014) 0.78
Ocular drug delivery for glaucoma management. Pharmaceutics (2012) 0.77
Vascular endothelial growth factor receptor 1 morpholino decreases angiogenesis in a murine corneal suture model. Invest Ophthalmol Vis Sci (2012) 0.77
Age-related eye disease study caveats. Arch Ophthalmol (2002) 0.75
Accelerated 20-year sunlight exposure simulation of a photochromic foldable intraocular lens in a rabbit model. J Cataract Refract Surg (2011) 0.75
Endocapsular carousel technique phacoemulsification. J Cataract Refract Surg (2011) 0.75
Minus Piggyback Lens Overlaying ReSTOR(®) Multifocal Lens in High Myopia. Case Rep Ophthalmol (2013) 0.75
Tarantula hairs as corneal foreign bodies. Case Rep Ophthalmol (2011) 0.75
Eyelid disease. Ophthalmology (2005) 0.75
Scanning electron microscopy visualization of methicillin-resistant Staphylococcus aureus after contact with gatifloxacin with and without preservative. J Ocul Pharmacol Ther (2010) 0.75
Pharmacokinetics and efficacy of Bioerodible Dexamethasone implant in Concanavalin A-induced uveitic cataract rabbit model. Pharm Res (2014) 0.75